Roger J. Packer

Active 1983–2025

245
Papers
42,729
Citations
126
h-index
239
i10-index

Citations

Citations per year for Roger J. Packer1930: 1 citations1984: 1 citations1985: 1 citations1986: 4 citations1987: 9 citations1988: 10 citations1989: 19 citations1990: 34 citations1991: 40 citations1992: 32 citations1993: 52 citations1994: 75 citations1995: 58 citations1996: 66 citations1997: 90 citations1998: 89 citations1999: 161 citations2000: 148 citations2001: 118 citations2002: 158 citations2003: 196 citations2004: 200 citations2005: 199 citations2006: 203 citations2007: 222 citations2008: 258 citations2009: 326 citations2010: 242 citations2011: 245 citations2012: 235 citations2013: 236 citations2014: 245 citations2015: 236 citations2016: 254 citations2017: 269 citations2018: 232 citations2019: 956 citations2020: 1,125 citations2021: 970 citations2022: 930 citations2023: 661 citations2024: 1,081 citations2025: 465 citations2026: 21 citations1931–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,562 citing papers, 33.6% of this breakdownCanada: 734 citing papers, 6.9% of this breakdownUnited Kingdom: 732 citing papers, 6.9% of this breakdownGermany: 725 citing papers, 6.8% of this breakdownChina: 468 citing papers, 4.4% of this breakdownItaly: 462 citing papers, 4.3% of this breakdownFrance: 445 citing papers, 4.2% of this breakdownNetherlands: 391 citing papers, 3.7% of this breakdownAustralia: 279 citing papers, 2.6% of this breakdownSwitzerland: 273 citing papers, 2.6% of this breakdownSpain: 201 citing papers, 1.9% of this breakdownJapan: 189 citing papers, 1.8% of this breakdown
0%33.6%Other 20.3%

Fields

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Neuroscience3.5%
  • Computer Science1%
  • Engineering0.6%
  • Immunology and Microbiology0.6%
  • Other1.8%

Topics

  • Glioma Diagnosis and Treatment15.2%
  • Childhood Cancer Survivors' Quality of Life4.4%
  • Neuroblastoma Research and Treatments4.4%
  • Meningioma and schwannoma management4.2%
  • Neurofibromatosis and Schwannoma Cases4.2%
  • Brain Metastases and Treatment3.2%
  • Other64.4%

Coauthors

All papers

Open in search
  1. Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 266

  2. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

    Authors: , , , - Nature Reviews Neurology 2022 cited by 298

  3. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liat Oren, Enrica E. K. Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley A. Walter, Daniel Da Costa, Peter Manley, Samuel C. Blackman, Roger J. Packer, Karsten Nysom - Nature Medicine 2023 cited by 177

  4. The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Koen Van Leemput, Hongwei Li, Nazanin Maleki, McAllister, Aaron S, Zeke Meier, Bjoern Menze, Ahmed W. Moawad, Nandolia, Khanak K, Pavaine, Julija, Marie Piraud, Tina Young Poussaint, Prabhu, Sanjay P, Zachary J. Reitman, Rodriguez, Andres, Jeffrey D. Rudie, Sanchez-Montano, Mariana, Ibraheem S Shaikh, Shah, Lubdha M., Sheth, Nakul, Russel T. Shinohara, Wenxin Tu, Karthik Viswanathan, Chunhao Wang, Jeffrey B. Ware, Benedikt Wiestler, Walter F. Wiggins, Anna Zapaishchykova, Mariam Aboian, Miriam Bornhorst, Peter de Blank, Michelle Deutsch, Maryam Fouladi, Lindsey M. Hoffman, Benjamin H. Kann, Margot Lazow, Leonie G. Mikael, Ali Nabavizadeh, Roger J. Packer, Adam Resnick, Brian R. Rood, Arastoo Vossough, Spyridon Bakas, Marius George Linguraru - arXiv (Cornell University), CoRR 2023 cited by 60

  5. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa L. Merker, Miriam J. Smith, David A. Stevenson, Monique Anten, Arthur S. Aylsworth, Diana Baralle, S. Barbarot, Fred G. Barker, Shay Ben‐Shachar, Amanda L. Bergner, D. Bessis, Ignacio Blanco, Cathérine Cassiman, Patricia Ciavarelli, Maurizio Clementi, Thierry Frébourg, Marco Giovannini, Dorothy Halliday, Chris Hammond, C. Oliver Hanemann, Helen Hanson, Arvid Heiberg, K.H. Ly, Michel Kalamarides, Matthias A. Karajannis, Daniela Kroshinsky, Margarita Larralde, Conxi Lázaro, Lu Q. Le, Michael P. Link, Robert Listernick, Mia MacCollin, Conor Mallucci, Christopher L. Moertel, Amy Mueller, Joanne Ngeow, Rianne Oostenbrink, Roger J. Packer, Laura Papi, Allyson Parry, Juha Peltonen, Dominique C. Pichard, Bruce Poppe, Nilton Alves de Rezende, Luiz Oswaldo Carneiro Rodrigues, Tena Rosser, Martino Ruggieri, Eduard Serra, Verena Steinke‐Lange, Stavros Stivaros, Amy Taylor, Jaan Toelen, James H. Tonsgard, Eva Trevisson, Meena Upadhyaya, Ali Varan, Meredith Wilson, Hao Wu, Gelareh Zadeh, Susan Huson, D. Gareth Evans, Scott R. Plotkin - Genetics in Medicine 2021 cited by 771

  6. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Austin Doyle, Malcolm A. Smith, Ira J. Dunkel, Maryam Fouladi - The Lancet Oncology 2019 cited by 502

  7. The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

    Authors: , - Neuro-Oncology 2021 cited by 245

  8. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 234

  9. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hetal Dholaria, Renee Doughman, Martin Benesch, Rachid Drissi, Javad Nazarian, Nada Jabado, Nathalie Boddaert, Pascale Varlet, G Giraud, David Castel, Stéphanie Puget, Chris Jones, Esther Hulleman, Piergiorgio Modena, Marzia Giagnacovo, Manila Antonelli, Torsten Pietsch, Gerrit H. Gielen, David Jones, Dominik Sturm, Stefan M. Pfister, Nicolas U. Gerber, Michael A. Grotzer, Elke Pfaff, André O. von Bueren, Darren Hargrave, Guirish A. Solanki, Filip Jadrijević Cvrlje, Gertjan J.L. Kaspers, W. Peter Vandertop, Jacques Grill, Simon Bailey, Veronica Biassoni, Maura Massimino, Raphaël Calmon, Esther Sánchez, Brigitte Bison, Monika Warmuth‐Metz, James Leach, Blaise V. Jones, Dannis G. van Vuurden, Christof M. Kramm, Maryam Fouladi - Journal of Clinical Oncology 2018 cited by 435

  10. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Luisa Garrè, Paolo Nozza, Samantha Mascelli, Alessandro Raso, Sabine Mueller, Theodore Nicolaides, Karen Silva, Romain Perbet, Alexandre Vasiljevic, Cécile Faure‐Conter, Didier Frappaz, Sarah Leary, Courtney A. Crane, Aden Ka‐Yin Chan, Ho‐Keung Ng, Zhifeng Shi, Ying Mao, Elizabeth Finch, David D. Eisenstat, Bev Wilson, Anne Sophie Carret, Péter Hauser, David Sumerauer, Lenka Krsková, Valérie Larouche, Adam Fleming, Shayna Zelcer, Nada Jabado, James T. Rutka, Peter B. Dirks, Michael D. Taylor, Shiyi Chen, Ute Bartels, Annie Huang, David W. Ellison, Éric Bouffet, Cynthia Hawkins, Uri Tabori - Journal of Clinical Oncology 2017 cited by 346

  11. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Kordes, David E. Kram, Matija Snuderl, Leslie Bridges, Andrew Martin, Lawrence J. Doey, Safa Al‐Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K.R. Boult, Simon P. Robinson, Martin Sill, Ira J. Dunkel, Stephen W. Gilheeney, Marc K. Rosenblum, Debbie Hughes, Paula Proszek, Tobey J. MacDonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger J. Packer, Ho‐Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D. Wood, Lissa Baird, Monika A. Davare, David A. Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane Cryan, Michael Capra, Michael Karremann, Jens Schittenhelm, Martin U. Schuhmann, Martin Ebinger, Winand N.M. Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C. Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi‐Camassei, Simon Bailey, Andrew S. Moore, Tim Hassall, Stephen P. Lowis, Maria Tsoli, Mark J. Cowley, David S. Ziegler, Matthias A. Karajannis, Kristian Aquilina, Darren Hargrave, Fernando Carceller, Lynley V. Marshall and 14 more - Cancer Discovery 2020 cited by 278

  12. The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 666

  13. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2016 cited by 650

  14. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arthur S. Aylsworth, Diana Baralle, S. Barbarot, Fred G. Barker, Shay Ben‐Shachar, Amanda L. Bergner, D. Bessis, Ignacio Blanco, Cathérine Cassiman, Patricia Ciavarelli, Maurizio Clementi, Thierry Frébourg, Alicia Gomes, Dorothy Halliday, Chris Hammond Helen Hanson Arvid Heiberg, K.H. Ly, Justin T. Jordan, Matthias A. Karajannis, Daniela Kroshinsky, Margarita Larralde, Conxi Lázaro, Lu Q. Le, Michael P. Link, Robert Listernick, Conor Mallucci, Vanessa L. Merker, Christopher L. Moertel, Amy Mueller, Joanne Ngeow, Rianne Oostenbrink, Roger J. Packer, Allyson Parry, Juha Peltonen, Dominique C. Pichard, Bruce Poppe, Nilton Alves de Rezende, Luiz Oswaldo Carneiro Rodrigues, Tena Rosser, Martino Ruggieri, Eduard Serra, Verena Steinke‐Lange, Stavros Stivaros, Amy Taylor, Jaan Toelen, James H. Tonsgard, Eva Trevisson, Meena Upadhyaya, Ali Varan, Meredith Wilson, Hao Wu, Gelareh Zadeh, Susan Huson, P. Wolkenstein, D. Gareth Evans - Genetics in Medicine 2022 cited by 276

  15. Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lili‐Naz Hazrati, Annie Huang, Sarah G. Injac, Valentina Iurilli, Matthias A. Karajannis, Gurcharanjeet Kaur, Martin Kynčl, Lenka Krsková, Normand Laperrière, Valérie Larouche, Álvaro Lassaletta, Sarah Leary, Frank Y. Lin, Samantha Mascelli, Tara McKeown, Till Milde, Andrés Morales La Madrid, Giovanni Morana, Helena Mörse, Naureen Mushtaq, Diana S. Osorio, Roger J. Packer, Zdeněk Pavelka, Eduardo Quiroga-Cantero, James T. Rutka, Magnus Sabel, Duarte Salgado, Palma Solano‐Páez, Jaroslav Štěrba, Jack Su, David Sumerauer, Michael D. Taylor, Helen Toledano, Derek S. Tsang, Mariana Valente Fernandes, Frank K.H. van Landeghem, Cornelis M. van Tilburg, Bev Wilson, Olaf Witt, Josef Zámečnı́k, Éric Bouffet, Cynthia Hawkins, Uri Tabori - JCO Precision Oncology 2020 cited by 142

  16. The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Florian Kofler, Dominic LaBella, Hollie Anne Lai, Koen Van Leemput, Hongwei Bran Li, Nazanin Maleki, Aaron S. McAllister, Zeke Meier, Bjoern H. Menze, Ahmed W. Moawad, Khanak K. Nandolia, Julija Pavaine, Marie Piraud, Tina Poussaint, Sanjay P. Prabhu, Zachary Reitman, Andres Felipe Rodriguez, Jeffrey D. Rudie, Mariana Sanchez-Montano, Ibraheem Salman Shaikh, Lubdha M. Shah, Nakul Sheth, Russell T. Shinohara, Wenxin Tu, Karthik Viswanathan, Chunhao Wang, Jeffrey B. Ware, Benedikt Wiestler, Walter I. Wiggins, Anna Zapaishchykova, Mariam Aboian, Miriam Bornhorst, Peter de Blank, Michelle Deutsch, Maryam Fouladi, Lindsey Hoffman, Benjamin H. Kann, Margot Lazow, Leonie Mikael, Ali Nabavizadeh, Roger J. Packer, Spyridon Bakas, Adam C. Resnick, Brian Rood, Arastoo Vossough, Marius George Linguraru - arXiv (Cornell University), CoRR 2024 cited by 26

  17. Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 435

  18. Pediatric high-grade glioma: biologically and clinically in need of new thinking

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2016 cited by 364

  19. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 195

  20. Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 158

  21. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 460

  22. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 320

  23. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 cited by 57

  24. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brigitte C. Widemann, Michael J. Fisher - Neuro-Oncology 2022 cited by 101